Recent ABCL News
- AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies • Business Wire • 05/01/2024 01:00:00 PM
- AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024 • Business Wire • 04/08/2024 04:05:00 PM
- AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024 • Business Wire • 04/03/2024 08:05:00 PM
- AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024 • Business Wire • 03/19/2024 08:05:00 PM
- AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions • Business Wire • 03/11/2024 01:00:00 PM
- AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024 • Business Wire • 03/05/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 07:12:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:49:40 PM
- AbCellera Announces Resignation of Board Member • Business Wire • 02/23/2024 09:30:00 PM
- AbCellera to Present at Upcoming Investor Conferences in March • Business Wire • 02/23/2024 01:15:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/20/2024 09:49:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:27:58 PM
- AbCellera Reports Full Year 2023 Business Results • Business Wire • 02/20/2024 09:05:00 PM
- AbCellera to Report Full Year 2023 Financial Results on February 20, 2024 • Business Wire • 01/23/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 11:23:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 11:21:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 11:18:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 11:14:23 PM
- AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024 • Business Wire • 12/20/2023 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 11:08:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 10:28:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:45:10 PM
- AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023 • Business Wire • 11/16/2023 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/08/2023 08:29:53 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM